The dataset has been developed for the pathological reporting of resection specimens of primary carcinomas of the vulva.
In some patients with a prior diagnosis of vulval carcinoma (especially squamous), it is not clear whether a ‘new’ lesion is a recurrence or an independent neoplasm and the dataset can also be used for such tumours, especially when these ‘arise’ from the surface squamous epithelium. Molecular studies have shown that some of these ‘recurrent’ neoplasms exhibit similar mutations and are clonally related to the original tumour and are likely to represent true recurrences while others are clonally unrelated with different mutations and are likely to represent new neoplasms.
In those rare cases where more than one primary tumour is present, separate datasets should be completed for each neoplasm. These should include all the elements in this dataset, except for lymph node status which does not need to be documented separately for each tumour.
Haematopoietic neoplasms, mesenchymal neoplasms, mixed epithelial and mesenchymal neoplasms, malignant melanomas, other non-epithelial malignancies and metastatic tumours are excluded from this dataset.
These datasets were developed with the kind support of the International Society of Gynecological Pathologists (ISGyP).
2nd edition – October 2023. The 2nd edition of this dataset incorporates the 2021 International Federation of Gynaecology and Obstetrics (FIGO) staging for cancer of the vulva.
SUMMARY OF CHANGES
1st edition – August 2021
All editions of the dataset for Carcinoma of the vulva was developed by the following international team: